Takeda Pharmaceutical Co Ltd
NYSE:TAK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
C
|
Champion Pacific Indonesia Tbk PT
SWB:IUD
|
ID |
|
L
|
Liberty Latin America Ltd
OTC:LILAB
|
US |
|
W
|
Wells Fargo & Co
F:NWT
|
US |
|
Schlumberger NV
NYSE:SLB
|
US |
|
Himax Technologies Inc
NASDAQ:HIMX
|
TW |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
C
|
Coca-Cola Co
BMV:KO
|
US |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
F:MCH
|
FR |
|
J
|
Japan Real Estate Investment Corp
F:JUA
|
JP |
|
O
|
Osaka Gas Co Ltd
F:OSA
|
JP |
|
J
|
JB Hi-Fi Ltd
SWB:JB3
|
AU |
|
V
|
Volkswagen AG
OTC:VWAGY
|
DE |
|
C
|
Cleveland-Cliffs Inc
XETRA:CVA
|
US |
|
C
|
CarGurus Inc
F:0C6
|
US |
|
A
|
ASML Holding NV
MIL:ASML
|
NL |
|
V
|
Visteon Corp
SWB:VS51
|
US |
|
A
|
Asahi Kasei Corp
F:ASAA
|
JP |
Dividends
Dividend Yield
Takeda Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Takeda Pharmaceutical Co Ltd
TAK have decreased by 1%.
Payout Ratio
Takeda Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for TAK is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
TAK Price
Takeda Pharmaceutical Co Ltd
| Average Annual Return | -1.22% |
| Standard Deviation of Annual Returns | 14.56% |
| Max Drawdown | -24% |
| Market Capitalization | 8.1T USD |
| Shares Outstanding | 3 170 000 000 |
| Percentage of Shares Shorted | 0.16% |
